CapForce, Inc. (CFOR)
6.02
-0.88
(-12.75%)
USD |
OTCM |
Nov 05, 16:00
CapForce Total Assets (Quarterly) : 87.68M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.68M |
| March 31, 2026 | 37.45M |
| December 31, 2025 | 38.06M |
| September 30, 2025 | 12.64M |
| June 30, 2025 | 13.24M |
| March 31, 2025 | 9.418M |
| December 31, 2024 | 9.863M |
| September 30, 2024 | 5.470M |
| June 30, 2024 | 2.870M |
| March 31, 2024 | 2.872M |
| December 31, 2023 | 1.882M |
| September 30, 2023 | 18.13M |
| June 30, 2023 | 22.44M |
| March 31, 2023 | 26.51M |
| December 31, 2022 | 25.81M |
| September 30, 2022 | 32.96M |
| June 30, 2022 | 48.81M |
| March 31, 2022 | 64.26M |
| December 31, 2021 | 71.67M |
| September 30, 2021 | 62.29M |
| June 30, 2021 | 68.56M |
| March 31, 2021 | 75.16M |
| December 31, 2020 | 49.75M |
| September 30, 2020 | 44.70M |
| June 30, 2020 | 46.29M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.76M |
| December 31, 2019 | 10.42M |
| September 30, 2019 | 6.430M |
| June 30, 2019 | 8.932M |
| March 31, 2019 | 12.09M |
| December 31, 2018 | 8.950M |
| September 30, 2018 | 9.223M |
| June 30, 2018 | 12.13M |
| March 31, 2018 | 14.61M |
| December 31, 2017 | 6.620M |
| September 30, 2017 | 9.219M |
| June 30, 2017 | 4.991M |
| March 31, 2017 | 6.157M |
| December 31, 2016 | 8.984M |
| September 30, 2016 | 9.576M |
| June 30, 2016 | 13.85M |
| March 31, 2016 | 9.680M |
| December 31, 2015 | 13.76M |
| September 30, 2015 | 17.00M |
| June 30, 2015 | 11.80M |
| March 31, 2015 | 2.648M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | 14.31M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 96.05B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 591.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.40M |
| Shareholders Equity (Quarterly) | 74.28M |
| Debt to Equity Ratio | 0.0264 |
| Current Ratio | 4.273 |
| Net Debt Paydown Yield | 0.00% |